Technology | June 08, 2012

The Latest Advancement in Pre-Screening Technology for MRI

June 8, 2012 — With hundreds of installations in MRI suites on five continents, Kopp Development Inc., maker of ferromagnetic detectors for MRI safety, will introduce FerrAlert SOLO during the AAPM 2012.

Designed for facilities with a large outpatient population, FerrAlert SOLO is the latest advancement in pre-screening technology and is particularly attractive for budget-conscious facilities. In 2008 Congress passed the Medicare Improvements for Patients and Providers Act (MIPPA). CMS, which is part of HHS, states that as of January 1, 2012 all IDTFs (imaging centers) must be accredited by a designated accreditation organization. The requirements for accreditation include Environment of Care (EC) which refers to Sentinel Events (SE). The joint commission issued Sentinel Event Alert #38, which recognizes the use of Ferromagnetic Detectors to assist in the screening process. In addition, it references a study by Emanuel Kanal, M.D., the chair of the ACR MR Safety Committee and Steven Thomas, M.D.,  specifically on FerrAlert product.

FerrAlert SOLO is a highly sensitive ferromagnetic detector, incorporating Kopp Development’s unique, patented technology to detect and precisely locate offending ferrous objects anywhere on the body. Developed specifically for the MRI environment, FerrAlert detectors are the ONLY ferromagnetic detectors that identify the location of offending ferrous objects. This unique and timesaving feature makes them the preferred choice by hospitals and imaging centers worldwide.

“We introduced FerrAlert SOLO at the AHRA and RSNA conferences this year and are thrilled by the reception we received. In the last three months, we have already sold quite a few FerrAlert SOLO detectors and have bookings all the way through 2012” said Director of Marketing and Sales Anna Srb.

Due to the dramatic increase of MRI accidents, several safety and regulatory agencies now strongly recommend the use of ferromagnetic detectors: the Joint Commission, American College of Radiology, VA MRI Design Guide and others.

“We are so pleased that in these tight economic times, we can help to enhance MR safety by offering FerrAlert™ SOLO at a very affordable price” said president of the company, Keith Kopp.

For more information:

Related Content

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Alternative Technique Can Improve Brain Imaging for Restless Children
News | Pediatric Imaging | March 08, 2018
March 8, 2018 – Children often find it difficult to remain still for...
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Imaging Plays Key Role in Evaluating Injuries at Olympics
News | Orthopedic Imaging | February 28, 2018
The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of injury. When injuries...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
Overlay Init